Jiangsu CoWin Biotech Co., Ltd. (SHA:688426)

China flag China · Delayed Price · Currency is CNY
23.54
+0.57 (2.48%)
At close: Mar 10, 2026
2.79%
Market Cap 2.59B
Revenue (ttm) 193.05M
Net Income (ttm) -103.28M
Shares Out 109.93M
EPS (ttm) -0.94
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,111,053
Average Volume 1,197,209
Open 23.89
Previous Close 22.97
Day's Range 23.00 - 23.89
52-Week Range 15.24 - 33.67
Beta 0.83
RSI 30.62
Earnings Date Apr 24, 2026

About Jiangsu CoWin Biotech

Jiangsu CoWin Biotech Co., Ltd. engages in the research and development, production, and sale of biological products in China. The company provides molecular diagnostic raw material enzymes, nucleic acid collection and protection agents, nucleic acid extraction and purification kits, molecular diagnostic testing reagents, etc. It also offers medical device products, nucleic acid collection and protection, PCR, RT-PCR, and qPCR products, molecular diagnosis, isothermal amplification, nucleic acid mass spectrometry, next generation sequencing, nu... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 770
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688426
Full Company Profile

Financial Performance

In 2025, Jiangsu CoWin Biotech's revenue was 193.05 million, an increase of 53.36% compared to the previous year's 125.88 million. Losses were -103.28 million, -34.30% less than in 2024.

Financial Statements

News

There is no news available yet.